CBS 2019
CBSMD教育中心
English

分叉支架

科研文章

荐读文献

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents In vitro flow and optical coherence tomography comparison of two bailout techniques after failed provisional stenting for bifurcation percutaneous coronary interventions Feasibility and efficacy of the ultrashort side branch dedicated balloon in coronary bifurcation stenting The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club A randomized trial of bifurcation stenting technique in chronic total occlusions percutaneous coronary intervention The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations Anatomical Attributes of Clinically Relevant Diagonal Branches in Patients with Left Anterior Descending Coronary Artery Bifurcation Lesions
|<< 1 2 3 4 5 6 >>|

Clinical Trial2018 Mar 6;8(3):e020019.

JOURNAL：BMJ Open. Article Link

Treatment effects of systematic two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomised and multicentre DEFINITION II trial

Zhang JJ, Gao XF, Chen SL et al. Keywords: 2-stent strategy; Bifurcation lesions; Drug-eluting stents

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top